<DOC>
	<DOCNO>NCT02298244</DOCNO>
	<brief_summary>Some patient long history AF develop PH `` reactive '' type increase pulmonary vascular resistance due vasoconstriction structural change vascular wall . RFA PVI + RFA GP `` gold standard '' treatment patient persistent AF , respond optimal therapy . The rear area pulmonary artery bifurcation adjacent roof part front leave atrium . In projection area ganglionic plexus leave atrium , sympathetic nerve fiber pulmonary artery baroreceptor main pulmonary artery.Recent study show radiofrequency denervation pulmonary artery improve quality life patient PH .</brief_summary>
	<brief_title>Safety Procedure Pulmonary Artery Denervation Addition Pulmonary Vein Isolation Combined With Ganglionated Plexi Ablation Patients With Persistent Atrial Fibrillation Pulmonary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<mesh_term>Pathologic Processes</mesh_term>
	<criteria>Patients symptomatic , drug refractory AF ( inefficiency 1C III Class antiarrhythmic drug ) , history AF 6 month without restoration sinus rhythm . MPAP ≥25 mmHg PCWP≥15 mmHg Pulmonary vascular resistance ( PVR ) . The PVR = ( mPAPPCWP ) / carbon monoxide ] &gt; 2.5 wood unit Left ventricular ejection fraction &lt; 35 % Diameter LA &gt; 60 mm transthoracic echocardiography `` M '' Mode volume LA 140 ml Significant regurgitation mitral valve Uncorrected congenital heart disease RFA PVI , RFA GP , PADN history Foregoing heart surgery Life expectancy le 12 month WHO group I , III , IV , V pulmonary artery hypertension Tricuspid valve stenosis , pulmonary supravalve stenosis . Cancer Pregnancy Thromboembolism LA history Hyperthyroidism .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Pulmonary Hypertension</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Pulmonary Arterial Denervation</keyword>
	<keyword>Safety</keyword>
	<keyword>Pulmonary Arterial GP Ablation</keyword>
</DOC>